Management of empagliflozin and ertugliflozin may be suboptimal following an insurance carrier’s formulary updates. Pharmacists may improve the management.
M. Thomas Bateman Jr, PharmD, BCACP
Advertisement
Articles by M. Thomas Bateman Jr, PharmD, BCACP
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
CDC Officially Ends Hantavirus Response as Outbreak Risk Recedes
2
ATTR-CM Incidence, Prevalence Rose Sharply in the US
3
FDA Approves Palbociclib for HR+, HER2+ Breast Cancer Maintenance
4
Zanubrutinib Tops Rivals in Real-World CLL Survival Study
5